Evidence map›Paper›PMID 27991909›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2017

Lymphatic invasion and angiotropism in primary cutaneous melanoma.

Andrea P Moy, Lyn M Duncan, Stefan Kraft

Abstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. FluorescenceExperimental and therapeutic medicine · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrea P MoyDermatopathology Unit, Pathology Service, Massachusetts General Hospital, Boston, MA, USA.
Lyn M DuncanDermatopathology Unit, Pathology Service, Massachusetts General Hospital, Boston, MA, USA.
Stefan KraftDermatopathology Unit, Pathology Service, Massachusetts General Hospital, Boston, MA, USA.
Massachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Access of melanoma cells to the cutaneous vasculature either via lymphatic invasion or angiotropism is a proposed mechanism for metastasis. Lymphatic invasion is believed to be a mechanism by which melanoma cells can disseminate to regional lymph nodes and to distant sites and may be predictive of adverse outcomes. Although it can be detected on hematoxylin- and eosin-stained sections, sensitivity is markedly improved by immunohistochemistry for lymphatic endothelial cells. Multiple studies have reported a significant association between the presence of lymphatic invasion and sentinel lymph node metastasis and survival. More recently, extravascular migratory metastasis has been suggested as another means by which melanoma cells can spread. Angiotropism, the histopathologic correlate of extravascular migratory metastasis, has also been associated with melanoma metastasis and disease recurrence. Although lymphatic invasion and angiotropism are not currently part of routine melanoma reporting, the detection of these attributes using ancillary immunohistochemical stains may be useful in therapeutic planning for patients with melanoma.

Indexed as

Cell MovementDisease-Free SurvivalHistocytochemistryHumansImmunohistochemistryLymphatic MetastasisLymph NodesMelanomaMembrane GlycoproteinsNeoplasm InvasivenessNeoplasm Recurrence, LocalNeovascularization, PathologicPlatelet Endothelial Cell Adhesion Molecule-1PodoplaninPrognosisS100 ProteinsLYVE1 protein, humanMembrane GlycoproteinsPDPN protein, humanPlatelet Endothelial Cell Adhesion Molecule-1PodoplaninS100A1 proteinS100 ProteinsVesicular Transport Proteins

Identifiers

PMID27991909
OpenAlexW2565650238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.